Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Viatris Inc.
IPO Date: November 13, 2020
Sector: Healthcare
Industry: Pharma
Market Cap: $10.2B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.15 | 1.31%
Avg Daily Range (30 D): $0.13 | 1.50%
Avg Daily Range (90 D): $0.14 | 1.61%
Institutional Daily Volume
Avg Daily Volume: 8.36M
Avg Daily Volume (30 D): 11.78M
Avg Daily Volume (90 D): 11.26M
Trade Size
Avg Trade Size (Sh.): 193
Avg Trade Size (Sh.) (30 D): 221
Avg Trade Size (Sh.) (90 D): 212
Institutional Trades
Total Inst.Trades: 7,967
Avg Inst. Trade: $4.5M
Avg Inst. Trade (30 D): $6.23M
Avg Inst. Trade (90 D): $6.02M
Avg Inst. Trade Volume: .38M
Avg Inst. Trades (Per Day): 6
Market Closing Trades
Avg Closing Trade: $16.99M
Avg Closing Trade (30 D): $30.94M
Avg Closing Trade (90 D): $27.33M
Avg Closing Volume: 1.48M
   
News
Jun 6, 2025 @ 5:31 PM
Goldman Sachs Bullish On Branded Drug Upside At Te...
Source: Vandana Singh
Jun 2, 2025 @ 8:00 PM
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
Jun 2, 2025 @ 12:00 PM
Opus Genetics Announces LYNX-2 Phase 3 Trial Met i...
Source: N/A
May 31, 2025 @ 11:07 AM
VTRS CLASS NOTICE: Viatris Inc. Investors may have...
Source: N/A
May 29, 2025 @ 11:22 PM
VTRS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIR...
Source: N/A
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $-2.55 $.08 $-.27
Diluted EPS $-2.55 $.08 $-.27
Revenue $ 3.25B $ 3.75B $ 3.8B
Gross Profit $ 1.16B $ 1.46B $ 1.45B
Net Income / Loss $ -3042M $ 94.8M $ -326.4M
Operating Income / Loss $ -2882.2M $ 225.9M $ -239.9M
Cost of Revenue $ 2.09B $ 2.29B $ 2.35B
Net Cash Flow $ 20.2M $ 961.6M $ -97.4M
PE Ratio    
Splits
Oct 09, 2003:   3:2
Jan 28, 2003:   3:2